Near-Infrared Heat Lamp Therapy Research

This systematic review and meta-analysis by Tripodi et al. evaluated the effectiveness of red and near-infrared photobiomodulation (PBM) for treating tendinopathy disorders. The authors searched six databases through August 2020 and included 17 randomized controlled trials with a total of 835 participants.

The meta-analysis compared PBM as both a standalone treatment and an adjunctive therapy alongside exercise. When used alone, PBM showed comparable pain reduction to other interventions but smaller functional improvements. However, when combined with exercise, PBM produced significantly greater pain reduction (MD 1.06) and improved function (MD 5.65) compared to sham plus exercise.

Most included studies had low risk of bias, though the overall quality of evidence ranged from very low to moderate per GRADE assessment. The authors concluded that PBM has utility as both a standalone and adjunctive therapy for tendinopathy, with the strongest evidence supporting its combination with exercise programs.

This review by Glass examined the clinical evidence for photobiomodulation (PBM) using low-level red and near-infrared light therapy across a range of medical and aesthetic applications. The paper synthesizes evidence for conditions including facial wrinkles, skin discoloration, acne, wound healing, body contouring, and androgenic alopecia.

The author explains the core mechanism: red and near-infrared light energy enhances mitochondrial ATP production, strengthens cellular function, and reduces oxidative damage. The review found a reasonable body of clinical trial evidence supporting the safety and efficacy of red/NIR light for skin rejuvenation, acne treatment, and hair loss management.

However, Glass highlights significant limitations in the existing literature, including small patient samples, industry funding bias, and unclear equivalence between LED and laser delivery systems. The review notes that commercial expansion of PBM devices has considerably outpaced rigorous, independent research, calling for well-designed clinical trials to establish definitive therapeutic value.

This systematic review by Salehpour, Khademi, and Hamblin examined the evidence for photobiomodulation (PBM) therapy as a treatment for dementia. The authors searched literature from 1967 to 2020 following PRISMA guidelines, screening 10,473 initial articles and ultimately including 36 studies that met their criteria.

The included studies spanned three categories: 9 in vitro studies, 17 animal model studies, and 10 clinical studies in dementia patients. Notably, all included studies reported positive results for PBM in dementia-related outcomes. The review extracted data on light sources, wavelengths, power output, irradiance, treatment duration, dosage, and outcomes.

While the preclinical evidence was encouraging, the authors acknowledged that clinical studies were limited by small patient numbers and the lack of placebo controls in some cases. They concluded that the preliminary evidence of clinical benefit, the absence of adverse effects, and the ease of use of PBM warrant larger, well-controlled clinical trials to establish definitive efficacy for dementia treatment.